Insights

Loading spinner
Gathering insights about Keen Eye

Keen Eye Tech Stack

Keen Eye uses 8 technology products and services including Docker, Unpkg, Cloudflare, and more. Explore Keen Eye's tech stack below.

  • Docker
    Containerization
  • Unpkg
    Content Delivery Network
  • Cloudflare
    Content Management System
  • WordPress
    Content Management System
  • Jenkins
    Continuous Integration
  • jQuery
    Javascript Libraries
  • Adobe Creative Suite
    Visualisation Software
  • Flask
    Web Frameworks

Media & News

Keen Eye's Email Address Formats

Keen Eye uses at least 2 format(s):
Keen Eye Email FormatsExamplePercentage
First.Last@keeneye.techJohn.Doe@keeneye.tech
67%
Last@keeneye.techDoe@keeneye.tech
33%
FLast@tribun.healthJDoe@tribun.health
100%

Frequently Asked Questions

Where is Keen Eye's headquarters located?

Minus sign iconPlus sign icon
Keen Eye's main headquarters is located at 2, Rue du Capitaine Scott, Paris, Île-de-France 75015, FR. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Keen Eye's official website and social media links?

Minus sign iconPlus sign icon
Keen Eye's official website is tribun.health and has social profiles on LinkedInCrunchbase.

What is Keen Eye's SIC code NAICS code?

Minus sign iconPlus sign icon
Keen Eye's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Keen Eye have currently?

Minus sign iconPlus sign icon
As of October 2025, Keen Eye has approximately 11 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Assistant Project Manager: K. K.Designer: M. L.. Explore Keen Eye's employee directory with LeadIQ.

What industry does Keen Eye belong to?

Minus sign iconPlus sign icon
Keen Eye operates in the Biotechnology Research industry.

What technology does Keen Eye use?

Minus sign iconPlus sign icon
Keen Eye's tech stack includes DockerUnpkgCloudflareWordPressJenkinsjQueryAdobe Creative SuiteFlask.

What is Keen Eye's email format?

Minus sign iconPlus sign icon
Keen Eye's email format typically follows the pattern of First.Last@keeneye.tech. Find more Keen Eye email formats with LeadIQ.

How much funding has Keen Eye raised to date?

Minus sign iconPlus sign icon
As of October 2025, Keen Eye has raised $6.7M in funding. The last funding round occurred on Apr 29, 2019 for $6.7M.

When was Keen Eye founded?

Minus sign iconPlus sign icon
Keen Eye was founded in 2012.
Keen Eye

Keen Eye

Biotechnology ResearchFrance11-50 Employees

Keen Eye is the AI platform company that elevates computational pathology to guide better drug development and diagnostics. 
*** Keen Eye has recently been acquired by Tribun Health*** 
Tribun Health powers the digital transformation of cancer diagnosis by designing innovative AI-based solutions to enable the management, analysis and sharing of pathology images for diagnostic labs, pharmaceutical and CRO companies.
Please also check the Tribun Health website: https://www.tribun.health/

Section iconCompany Overview

Headquarters
2, Rue du Capitaine Scott, Paris, Île-de-France 75015, FR
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $6.7M

    Keen Eye has raised a total of $6.7M of funding over 2 rounds. Their latest funding round was raised on Apr 29, 2019 in the amount of $6.7M.

  • $1M

    Keen Eye's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $6.7M

    Keen Eye has raised a total of $6.7M of funding over 2 rounds. Their latest funding round was raised on Apr 29, 2019 in the amount of $6.7M.

  • $1M

    Keen Eye's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.